HCi Viocare Ships Smart Diabetic Walker Boot

Medical Device Investing

HCi Viocare shipped its first smart diabetic walker boot to a global diabetes-market leading.

HCi Viocare (OTCQB:VICA) shipped its first smart diabetic walker boot to a global diabetes-market leading.
As quoted in the press release:

The Flexisense smart diabetic walker allows the user or the clinician to identify high pressure or shear force areas without having to remove the boot. Removing the walker throughout the day to check for pressure sores could lead to prolonged healing time. The smart boot is especially useful for diabetic user who must ensure their feet are kept clean and in good condition. Any high forces or pressure points can be analysed and resolved immediately, rather than at the end of the day, which can be too late. If sores are prevented, then there would be a reduction in diabetic ulcers which can cause serious health problems, are expensive to treat and can lead to amputation.
According to the WHO[1] there are 422 million people with diabetes world-wide, and 25% of them will develop diabetic foot condition at some point in their lives. In the USA alone the cost of treatment for foot ulcers has surpassed the 13 billion dollars mark and continues to rise[2]. The importance of a smart diabetic walker that can monitor ulcerations is therefore paramount.

Click here to read the full press release.

Source: www.marketwired.com

The Conversation (0)
MARKETS
COMMODITIES
CURRENCIES
Ă—